New study to assess custom prosthetics for bone cancer patients
NCT ID NCT07337018
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how well people do after surgery to remove bone tumors and rebuild the bone with special implants. It includes 100 adults aged 30 to 70 with certain bone cancers or tumors that have spread to bone. The goal is to learn more about how these custom or 3D-printed prosthetics work over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2026
An estimate. Start dates often move.
- Expected to finish
-
Nov 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with primary or secondary bone tumors treated at the Policlinico A. Gemelli
- Ages
-
30 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age between 30 and 70 years; Diagnosis of primary malignant or locally aggressive benign bone tumors, or secondary bone lesions with a primary diagnosis of breast, lung, prostate, kidney, or thyroid cancer; Extensive bone loss precluding the use of currently available prostheses or standard surgical techniques; Use of modular or custom-made prostheses produced with 3D-printing technology; minimum follow-up of 12 months; (For patients in the retrospective phase) completion of evaluation questionnaires during outpatient follow-ups; Obtaining Informed Consent, except for deceased patients enrolled in the retrospective phase of the study. Exclusion Criteria: Patients with disease spread to other bone segments; Age \<30 years or \>70 years; Patients who have undergone previous surgical procedures on the involved segment; Follow-up of less than 1 year; Incomplete clinical or radiological data sets; Inability to obtain Informed Consent, except for deceased patients enrolled in the retrospective phase of the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bone tumor are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive injection target bone tumors? a Dose-Finding trial aims to find out
- Blood test may reveal hidden cancer spread without scans
- Can a simple blood draw reduce transfusions in bone cancer surgery?
- Hip bone reconstruction after cancer: a 30-Year review
- Weekly scans may make proton therapy safer for kids with cancer
- Bone cancer rehab: will patients follow their home workouts?